Ciprofloxacin ear drops
قطره گوش سیپروفلوکساسین
👁️ Sensory OrgansTopical otic fluoroquinolone
Market / country: 🇺🇸 USA
Cetraxal (US)
🧮 Dose calculator
Otitis externa · Regimen source: FDA Ciprofloxacin otic · 2
- • Warm the container in the hand to avoid dizziness; affected ear upward. FDA Ciprofloxacin otic · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to ciprofloxacin. FDA Ciprofloxacin otic · 4
- ⛔ Not established under 1 year. FDA Ciprofloxacin otic · 8.4
Formulations
- 0.2% single-dose container (0.25 mL) — drops 🇺🇸 USA FDA Ciprofloxacin otic · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ciprofloxacin otic · 8.1
“Pregnancy Category C.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Ciprofloxacin otic · 8.3
“Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ciprofloxacin otic · 8.4
“The safety and effectiveness of ciprofloxacin otic solution, 0.2% in infants below one year of age have not been established.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Ciprofloxacin otic · 8.5
“No overall differences in safety and effectiveness have been observed between elderly and younger patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA217887
- DailyMed (FDA label)FDA Ciprofloxacin otic
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDS02AA15
- Darooyab (Iran)Ciprofloxacin
🇮🇷 Registered in Iran Darooyab · G-361/Ciprofloxacin
Dosage forms with Iranian generic codes, per Darooyab.
- 09786 · CIPROFLOXACIN 250MG/5ML 100ML SUSP · سوسپانسیون سیپروفلوکساسین ۲۵۰ میلیگرم / ۵ میلیلیتر ۱۰۰ میلیلیتر
- 00295 · CIPROFLOXACIN HCL 250MG TAB · قرص سیپروفلوکساسین هیدروکلراید ۲۵۰ میلیگرم
- 00296 · CIPROFLOXACIN HCL 500MG TAB · قرص سیپروفلوکساسین هیدروکلراید ۵۰۰ میلیگرم
- 10757 · CIPROFLOXACIN LACTATE 200MG/100ML INF BOTTLE · محلول انفوزیون در بطری سیپروفلوکساسین لاکتات ۲۰۰ میلیگرم / ۱۰۰ میلیلیتر
- 00294 · CIPROFLOXACIN LACTATE 200MG/100ML INF P-BAG · محلول انفوزیون سیپروفلوکساسین لاکتات ۲۰۰ میلیگرم / ۱۰۰ میلیلیتر
- 02250 · CIPROFLOXACIN LACTATE 200MG/20ML INF · محلول انفوزیون سیپروفلوکساسین لاکتات ۲۰۰ میلیگرم / ۲۰ میلیلیتر
- 52076 · CIPROFLOXACIN INJECTION, SOLUTION INTRAVENOUS 10 mg/1mL 40 mL · فرآورده تزریقی سیپروفلوکساسین ۱۰ میلیگرم / ۱ میلیلیتر ۴۰ میلیلیتر
- 52435 · CIPROFLOXACIN (AS HYDROCHLORIDE) TABLET ORAL 750 mg · قرص سیپروفلوکساسین (معادل هیدروکلراید) ۷۵۰ میلیگرم
- 52801 · CIPROFLOXACIN (AS LACTATE) INJECTION, SOLUTION INTRAVENOUS 2 mg/1mL 200 mL · فرآورده تزریقی سیپروفلوکساسین (معادل لاکتات) ۲ میلیگرم / ۱ میلیلیتر ۲۰۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Ciprofloxacin otic · 3FDA Ciprofloxacin otic · 2FDA Ciprofloxacin otic · 4FDA Ciprofloxacin otic · 8.4FDA Ciprofloxacin otic · 8.1FDA Ciprofloxacin otic · 8.3FDA Ciprofloxacin otic · 8.5FDA Ciprofloxacin otic · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-361/Ciprofloxacin
- Clinical review⚠ Unverified